Skip to main content

Table 1 Characteristics of the IVIG-treated group and the control group

From: High-dose of intravenous immunoglobulin modulates immune tolerance in premature infants

  IVIG Control P value
Patients 31 21  
Gender
Male 16 12 0.7626
Female 15 9  
GA (w, median) 33.5 (32.0–36.1) 34.1 (30.1–36.3) 0.1082
BW (g, median) 2025 (1520–2670) 2096(1540–2810) 0.4923
Mode of delivery    0.755
Vaginal 7 5  
Cesarean 24 16  
Preterm reasons
PROM 19 15 0.194
PIH 9 4 0.064
PP 3 2 1
NCPAP    0.127
Yes 16 9  
No 15 12  
Apgar at 1 min 7.43 7.85 0.1263
Apgar at 5 min 8.71 9 0.2421
Hospital stay (d) 15.2 12.67 0.0549
Prognosis Cure Cure  
  1. GA Gestational age, BW Birth of weight, PROM Premature rupture of membranes, PIH pregnancy-induced hypertension, PP placenta previa, NCPAP nasal continuous positive airway pressure
\